Skip to main content
logo
Solara Active Pharma Sciences Limited (NSE:SOLARA)
India flag India · Delayed Price · Currency is INR
547.40
+14.70 (2.76%)
Jun 1, 2026, 3:30 PM IST

NSE:SOLARA Revenue

In the fiscal year ending March 31, 2026, Solara Active Pharma Sciences had annual revenue of 13.75B INR with 7.12% growth. Solara Active Pharma Sciences had revenue of 3.92B in the quarter ending March 31, 2026, with 43.58% growth.

Revenue
13.75B
Revenue Growth
+7.12%
P/S Ratio
1.92
Revenue / Employee
7.75M
Employees
1,775
Market Cap
26.37B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202613.75B913.80M7.12%
Mar 31, 202512.84B-51.60M-0.40%
Mar 31, 202412.89B-1.55B-10.73%
Mar 31, 202314.44B1.75B13.83%
Mar 31, 202212.68B-3.49B-21.56%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Indoco Remedies18.45B
Aarti Pharmalabs18.29B
Innova Captab16.30B
Windlas Biotech9.04B
Orchid Pharma8.47B
RPG Life Sciences7.08B
Ind-Swift Laboratories6.88B
Beta Drugs3.85B
Revenue Rankings

Solara Active Pharma Sciences News

More News